SHARMAN MOORE: Open Payments
NPI 1437150687 · LOCKNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 63 payments from 20 companies in 2025. Trend: 2023 $459 · 2024 $1,411 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $276 |
| ABBVIE INC. | 10 | $160 |
| Lilly USA, LLC | 8 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Abbott Laboratories | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 3 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Antares Pharma, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
Products named: MOUNJARO, Wegovy, Ozempic, VRAYLAR, QULIPTA, REXULTI, CAPLYTA, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
